{"nct_id":"NCT02032823","title":"Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-07","start_date":"2014-04-22","start_date_type":"ACTUAL","primary_completion_date":"2020-03-27","primary_completion_date_type":"ACTUAL","completion_date":"2029-05-28","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}